Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.
about
Antiphospholipid antibodies: paradigm in transition.Management of the antiphospholipid syndromeAntiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.Impaired fibrinolysis in the antiphospholipid syndrome.Idiopathic venous thromboembolism and thrombophiliaIncreased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex AssayBouquet variety of antiphospholipid antibodies in recurrent pregnancy lossAntiphospholipid Syndrome during pregnancy: the state of the artCardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.The antiphospholipid syndrome: still an enigmaImmunomodulatory effects of therapeutic plasma exchange on monocytes in antiphospholipid syndrome.Clinical Application of Revised Laboratory Classification Criteria for Antiphospholipid Antibody Syndrome: Is the Follow-Up Interval of 12 Weeks Instead of 6 Weeks Significantly Useful?Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value.Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function.Current management of antiphospholipid syndrome-related thrombosis.Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment.Pathogenesis of antiphospholipid syndrome: understanding the antibodies.Guidelines on the investigation and management of antiphospholipid syndrome.Obstetric and vascular APS: same autoantibodies but different diseases?Antiphospholipid antibody testing and standardization.Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review.Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.Antiphospholipid syndrome: A diagnostic challenge.Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.Phospholipid-binding proteins differ in their capacity to induce autoantibodies and murine systemic lupus erythematosus.Diagnosis and management of the antiphospholipid syndrome.Invitation to a debate on the serological criteria that define the antiphospholipid syndrome.Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome.Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
P2860
Q33382848-25C439AD-2DB5-46E0-B6D0-DCD79A40F1A7Q33423034-9FD60404-E795-4D52-B900-592F0BD572BFQ33435408-12A2E1AC-5A42-4CCF-8BB6-23DEB4AC3F9CQ33822542-E7A4180C-2FFF-4708-98B9-D2DE03A9200DQ34666620-B0229785-27CE-4DE0-8E58-943B45E61588Q35625927-2CD6D240-7047-4C27-99F0-E9EE7A079AE8Q35631774-20D0CABF-E62F-4FEB-88E8-8C3CCDED1D41Q35756040-5F4B2828-38BE-4B3A-950A-540592681DC4Q36303250-F1A2F7F1-84E6-4F36-BD6F-9A683E08D8B6Q36928593-AC2D17E7-0773-4E36-B014-FA8ED821DFEBQ37107209-B8CCBAC2-0D6F-4F60-A68C-C1FB0714096FQ37218750-54FFFE64-9691-4266-9907-5DA4D002AC1FQ37244052-2421AC7E-5F2A-43A1-A507-8B5AD7B6517EQ37283006-49C211D4-3D67-485A-B028-258C8C7EB8ACQ37283017-90B1CA06-81C9-4BBF-B4D5-B43187C2E91BQ37642830-5A0F4756-8920-403E-9A91-6446130B90BDQ37842673-7AC7E6B9-7BA0-49D6-AC39-F399A4D341A1Q37873720-93B1C846-1A94-4AB9-AD42-E47C3AC8DAA6Q37982121-DB1DE9C2-816F-4782-B0D8-5BF9625D5EEFQ38013583-84E9D561-1D8E-4B5E-90AC-0A4A14757730Q38205953-C48BBEF1-3DE6-4DB4-A404-64807C9280C1Q38205954-EC65CEBB-1612-4E40-AD85-C5D005866F8CQ38596401-F5071E68-85BB-48E8-887B-09BA40C662E1Q38657043-7352F3CF-4FAB-4BC9-9611-871930F810CBQ38856073-4EDF6860-0202-45C8-9B6F-E622849FE43EQ39066464-681DE27D-86E0-4133-8179-ECBFAC3C92C0Q39502745-BA3A750E-F4A8-4459-B74B-78CB6BD9637AQ41619784-9F72BDEC-D914-4318-9997-89C499064F7CQ44338705-5CF6E9F6-BC34-4895-8DED-442ABA06D87CQ44488536-B8A864E7-0162-42CC-B44A-F61071010E86Q46586191-984E5677-11E6-4BF4-887E-D5829475F520Q47982275-9AA3E3E5-A4C3-4666-B100-F101481F06FBQ48034591-69FF7476-BDB8-40CF-9EC8-75AAD491174DQ48443751-4A0E90A1-DB61-4C56-8D39-AD7184058993Q49091040-B7317DC5-A1A1-4B98-9974-7292933B80A7Q49158813-8C5B4E06-CB5C-42EA-A7B5-701C01A3E08BQ51818187-711182BB-8BE4-4AC9-9F90-6E93B2EF1CBF
P2860
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical significance of diffe ...... iphospholipid syndrome) study.
@ast
Clinical significance of diffe ...... iphospholipid syndrome) study.
@en
Clinical significance of different antiphospholipid antibodies in the WAPS
@nl
type
label
Clinical significance of diffe ...... iphospholipid syndrome) study.
@ast
Clinical significance of diffe ...... iphospholipid syndrome) study.
@en
Clinical significance of different antiphospholipid antibodies in the WAPS
@nl
prefLabel
Clinical significance of diffe ...... iphospholipid syndrome) study.
@ast
Clinical significance of diffe ...... iphospholipid syndrome) study.
@en
Clinical significance of different antiphospholipid antibodies in the WAPS
@nl
P2093
P1433
P1476
Clinical significance of diffe ...... iphospholipid syndrome) study.
@en
P2093
Eva Marie Jacobsen
Finn Wisloff
Giovanna Borrelli
Guido Finazzi
Monica Galli
Olivier Morboeuf
Roberto Marchioli
Rosa Maria Marfisi
Stefana Marziali
Tiziano Barbui
P304
P356
10.1182/BLOOD-2007-01-066043
P407
P577
2007-04-17T00:00:00Z